Dr. Gary Slater received his Bachelor's degree in Electrical Engineering at Columbia University. He earned his M.D. degree from New York University School of Medicine. Dr. Slater trained in general surgery at The Mount Sinai Medical Center, during which time he was a trainee at the National Institute of Medical Sciences.
Currently, Dr. Slater is Professor of Surgery and Vice-Chair for Clinical Affairs at Mount Sinai Medical Center. He has an active general surgery practice and his academic interests are gastrointestinal tract surgery, colorectal surgery, inflammatory bowel disease, and hernia surgery.
American Board of Surgery
MD, New York University
Mount Sinai Hospital
English, Russian, Spanish
Investigator,\r\nTherapy of Patients with Large Bowel Carcinoma\r\nGastrointestinal Tumor Study Group (GITS)\r\n(1979-1981)
Greenstein AJ, Slater G, Heimann T, Sachar DB, Aufses Jr AH. A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli and de novo cancer. Ann Surg 1986; 203(2): 123-128.
Lawrence GD, Cohen G, Aufses Jr AH, Slater G. Lipid peroxidation in dimethylhydraxine-induced colon cancer: first colloqium in biological sciences. Ann N Y Acad Sci 1986; 435: 441-443.
Hermann G, Schwartz IS, Slater G. Drug-induced breast mass: case of the month. JAMA 1986; 255: 939-940.
Slater G, Kang J, Cohen G, Szporn A, Aufses Jr AH. In vivo ethane production in vitamin E-deficient rats with DMH-induced colon cancer. Surg Oncol 1987; 36: 142-147.
Greenstein AJ, Meyers S, Szporn A, Slater G, Janowitz HD, Aufses Jr AH. Colorectal cancer in regional ileitis. Q J Med 1987; 62: 33-40.
Slater G, Fleshner P, Aufses Jr AH. Colorectal cancer location and synchronous adenomas. Am J Gastroenterol 1988; 83: 832-836.
Kang JO, Slater G, Aufses Jr AH, Cohen G. Production of ethane by rats treated with the colon carcinogen l,2-dimethylhydrazine. Biochem Pharmacol 1988; 37: 2967-2971.
Kang JO, Slivka A, Slater G, Cohen G. In vivo formation of hydroxyl radicals following intragastric administration of ferrous salt in rats. J Inorg Biochem 1989; 35: 55-69.
Greenstein AJ, Present DH, Sachar DB, Slater G, Heimann T, Lachman P, Aufses Jr AH. Gastric fistulae in Crohn's disease. Dis Colon Rectum 1989; 32: 888-892.
Fleshner P, Slater G, Aufses Jr AH. Age and sex distribution of colorectal cancer. Dis Colon Rectum 1989; 32: 107-111.
Slater G, Aufses Jr AH, Szporn A. Synchronous carcinoma of the colon and rectum. Surgery, Gynec & Obst 1990; 171: 283-287.
Slater G, Aufses Jr AH. Small bowel length in Crohn's disease. Am J Gastroenterol 1991; 86: 1037-1040.
Slater G, Itzkowitz S, Azar S, Aufses Jr AH. Clinicopathologic correlations of ABO and rhesus blood type in colorectal cancer. Dis Colon Rectum 1993; 36: 5-7.
Slater G, Heimann T. Colectomy and ileoanal-pouch anastomosis for ulcerative colitis. Surg Rounds 1993; 16: 733-739.
Fleshner PR, Siegman MG, Slater G, Brolin RE, Chandler JC, Aufses Jr AH. A prospective, randomized trial of short versus long tubes in adhesive small-bowel obstruction. Am J Surg 1995; 170: 366-370.
Slater G. Complications of pregnancy: surgical aspects. Pract Gastroenterol 1995; 19: 15-26.
Aufses Jr AH, Slater GI, Hollier LH. The nature and fate of categorical surgical residents who 'drop out'. Am J Surg 1998; 175: 236-239.
Haber RS, Rathan A, Weiser KR, Pritsker A, Itzkowitz S, Slater G. GLUT1 Glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 1998; 83: 34-40.
Slater G, Greenstein AJ. Mesenteric fibromatosis in Crohn's disease. J Clin Gastroenterology 1998; 83: 34-40.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Slater did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.